Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-01-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.02.1436PMID 16365181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2005

  2005cited by this paper
• Stat bite: Age-adjusted lung cancer mortality rates, 1990-2000.

  2004cited by this paper
• Participation in cancer clinical trials: race-, sex-, and age-based disparities.

  2004cited by this paper
• Cancer survival in Kentucky and health insurance coverage.

  2003cited by this paper
• O-277 CALGB 9732: Final report of a randomized phase III intergroup trial of etoposide(VP-16) and cisplatin (DDP) with or without paclitaxel(TAX) and G-CSF in patients with extensive stage small cell lung cancer(ED-SCLC)

  2003cited by this paper
• The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

  2003cited by this paper
• Impact of referral patterns on the use of chemotherapy for lung cancer.

  2002cited by this paper
• Cancer Statistics for African Americans

  2002cited by this paper
• The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033

  2002cited by this paper
• Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

  2002cited by this paper
• Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).

  2002cited by this paper
• Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).

  2002cited by this paper
• Minority physicians' experiences obtaining referrals to specialists and hospital admissions.

  2001cited by this paper
• Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.

  2001cited by this paper
• Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.

  2001cited by this paper
• Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.

  2001cited by this paper
• The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.

  2001cited by this paper
• The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer

  2000cited by this paper
• Who gets chemotherapy for metastatic lung cancer?

  2000cited by this paper
• Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress.

  1999cited by this paper
• Race and outcomes: is this the end of the beginning for minority health research?

  1999cited by this paper
• The effect of race and sex on physicians' recommendations for cardiac catheterization.

  1999cited by this paper
• Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking.

  1999cited by this paper
• Cancer statistics for African Americans, 1996

  1996cited by this paper
• Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists.

  1995cited by this paper
• Differences in initial treatment patterns and outcomes of lung cancer in the elderly.

  1995cited by this paper
• Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

  1990cited by this paper
• Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

  1989cited by this paper
• Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states.

  1988cited by this paper
• Referral of lung cancer patients to university hospital cancer centers. A population‐based study in two rural states

  1988cited by this paper
• Cancer patient survival among ethnic groups in the United States.

  1984cited by this paper
• The analysis of failure times in the presence of competing risks.

  1978cited by this paper
• Keynote address on biostatistics and data retrieval.

  1973cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Survival Determinants and Treatment Outcomes of Patients with Small Cell Lung Cancer and Brain Metastases: A U.S. National Analysis

  2025cites this paper
• Social Disparities in Lung Cancer.

  2022cites this paper
• Survival of Black and White Patients With Stage IV Small Cell Lung Cancer

  2021cites this paper
• Eliminating disparities in endometrial cancer: adherence to high-quality care is not enough.

  2020cites this paper
• Lung Cancer in Nonelderly Patients: Facility and Patient Characteristics Associated With Not Receiving Treatment.

  2019cites this paper
• Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity.

  2018cites this paper
• Lung cancer health disparities.

  2018cites this paper
• Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma

  2017cites this paper
• Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations

  2017cites this paper
• Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.

  2017cites this paper
• Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages

  2017cites this paper
• Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies

  2017cites this paper
• Neutrophil to lymphocyte ratio associated with prognosis of lung cancer

  2017cites this paper
• Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military

  2015cites this paper
• Affordability in Health Care: Operationalizations and Applications in Different Contexts

  2014cites this paper
• Controversies in the management of stage III non-small-cell lung cancer

  2014cites this paper
• Important prognostic factors for lung cancer in tobacco predominant Eastern North Carolina: study based on a single cancer registry.

  2014cites this paper
• Editorial comment.

  2013cites this paper
• The use, effectiveness, and safety of bevacizumab in older adults with advanced stage non-small cell lung cancer

  2013cites this paper
• Place of residence and primary treatment of prostate cancer: examining trends in rural and nonrural areas in Wisconsin.

  2013cites this paper
• Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges

  2012cites this paper
• Lung Cancer Survival among Black and White Patients in an Equal Access Health System

  2012cites this paper
• Small-cell lung cancer: prognostic factors and changing treatment over 15 years.

  2012cites this paper
• Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study

  2012cites this paper
• What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program hospitals?

  2012cites this paper
• Diffusion of the EGFR Assay: The Underutilization and the Urban/Rural Divide

  2012cites this paper
• Health System Lung Cancer Survival among Black and White Patients in an Equal

  2012cites this paper
• The Prognostic Value of the Simplified Comorbidity Score in the Treatment of Small Cell Lung Carcinoma

  2011cites this paper
• Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States.

  2011cites this paper
• Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials

  2011cites this paper
• A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer

  2010cites this paper
• Small Cell Lung Cancer: Time to Diagnosis and Treatment

  2010cites this paper
• Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung

  2010cites this paper
• Do race and ethnicity predict survival in metastatic non-small cell lung cancer?

  2010cites this paper
• Do racial or socioeconomic disparities exist in lung cancer treatment?

  2010cites this paper
• Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.

  2009cites this paper
• Prognostic Factors for Survival in Extensive Stage Small Cell Lung Cancer (ED-SCLC): The Importance of Smoking History, Socioeconomic and Marital Statuses, and Ethnicity

  2009cites this paper
• Uncovering Disparities in Survival after Non–Small–Cell Lung Cancer among Asian/Pacific Islander Ethnic Populations in California

  2009cites this paper
• Race and Sex Differences in the Receipt of Timely and Appropriate Lung Cancer Treatment

  2009cites this paper
• Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer

  2008cites this paper
• Patient education level as a predictor of survival in lung cancer clinical trials.

  2008cites this paper
• Locally advanced non-small cell lung cancer: the past, present, and future.

  2008cites this paper
• Contemporary review on the inequities in the management of lung cancer among the African-American population.

  2008cites this paper
• Racial disparities in lung cancer.

  2007cites this paper
• Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.

  2007cites this paper
• Lung carcinoma in African Americans

  2007cites this paper
• The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma.

  2006cites this paper
• Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment.

  2006cites this paper